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Background: Differences in interlaboratory research protocols contribute to the conflicting data in
the literature regarding engineered nanomaterial (ENM) bioactivity.
Objectives: Grantees of a National Institute of Health Sciences (NIEHS)-funded consortium
program performed two phases of in vitro testing with selected ENMs in an effort to identify and
minimize sources of variability.
Methods: Consortium program participants (CPPs) conducted ENM bioactivity evaluations on
zinc oxide (ZnO), three forms of titanium dioxide (TiO2), and three forms of multiwalled carbon
nanotubes (MWCNTs). In addition, CPPs performed bioassays using three mammalian cell lines
(BEAS-2B, RLE-6TN, and THP-1) selected in order to cover two different species (rat and human),
two different lung epithelial cells (alveolar type II and bronchial epithelial cells), and two different
cell types (epithelial cells and macrophages). CPPs also measured cytotoxicity in all cell types while
measuring inflammasome activation [interleukin-1β (IL-1β) release] using only THP-1 cells.
Results: The overall in vitro toxicity profiles of ENM were as follows: ZnO was cytotoxic to all
cell types at ≥ 50 μg/mL, but did not induce IL-1β. TiO2 was not cytotoxic except for the nanobelt
form, which was cytotoxic and induced significant IL-1β production in THP-1 cells. MWCNTs
did not produce cytotoxicity, but stimulated lower levels of IL-1β production in THP-1 cells, with
the original MWCNT producing the most IL-1β.
Conclusions: The results provide justification for the inclusion of mechanism-linked bioactivity
assays along with traditional cytotoxicity assays for in vitro screening. In addition, the results suggest that conducting studies with multiple relevant cell types to avoid false-negative outcomes is
critical for accurate evaluation of ENM bioactivity.
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The worldwide development of innovative
products increasingly includes incorporating engineered nanomaterials (ENMs). It is
likely that ENM use will become ever more
commonplace in the future and provide many
benefits, although harm from inadvertent
human exposures may also increase. Some
challenges in evaluation of ENM safety need
to be addressed, especially considering that
the pace of ENM development is exceeding
the industry’s ability to sufficiently conduct
animal safety testing (Maynard et al. 2006;
Nel et al. 2006; Oberdörster et al. 2005). To
address this issue, one of the goals in the field
of nanotoxicology (or nanosafety) is development of in vitro assays that are highly predictive of in vivo outcomes in order to triage
those ENMs that should proceed to in vivo
testing (Meng et al. 2009; Oberdörster et al.
2005). Unfortunately, the presence of conflicting interlaboratory data on the relative
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hazard of individual ENMs is a concern for
moving the reliability of in vitro testing forward. Therefore, the National Institute of
Environmental Health Sciences (NIEHS)
developed a consortium program of experts in
the field of pulmonary toxicology to conduct
coordinated in vitro and in vivo assays with
selected well-characterized ENMs. There are
a number of potential causes of variability,
including sources of ENM, ENM suspension
protocols, selection of target cells, end points
selected to evaluate ENM bioactivity, and
details of cell culture and end point assays.
All consortium program participants
(CPPs) received characterized ENMs for use in
this study, including metal oxide nanospheres
[rutile/anatase titanium dioxide (TiO2-P25),
TiO2 anatase (TiO2-A), and zinc oxide (ZnO)]
and high-aspect-ratio materials [multiwalled
carbon nanotubes (MWCNTs) and TiO2
nanobelts (TiO 2-NBs)]. Furthermore, the
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CPPs tested three forms of MWCNT [original
(O-MWCNT), purified (P-MWCNT) and
functionalized (carboxylated) (F-MWCNT)].
The consortium chose cell lines for the assays
based on respiratory tract exposure, thus, the
cell types most likely to interact with ENM
after deposition. As such, the cell lines included
RLE-6TN (rat type II alveolar epithelial cell
line), BEAS-2B (human bronchial epithelial
cell line), and THP-1 (human monocyte/
macrophage cell line) (Dostert et al. 2008;
Driscoll et al. 1995; Xia et al. 2008b). The consortium developed ENM suspension protocols
(in cell culture media) that were sufficiently
reproducible among laboratories (Ji et al. 2010;
Porter et al. 2008; Sager et al. 2007). The cell
assays included traditional cytotoxicity testing
(Xia et al. 2008b) and evaluation of the Nodlike receptor protein 3 (NLRP3) inflammasome activation with THP-1 cells (Hamilton
et al. 2009). The consortium chose the
Address correspondence to A. Holian, 280 Skaggs
Building, Center for Environmental Health Sciences,
32 Campus Dr., The University of Montana,
Missoula, MT 59812 USA. Telephone: (406) 2434018 USA. E-mail: andrij.holian@mso.umt.edu
Supplemental Material is available online (http://
dx.doi.org/10.1289/ehp.1306561).
We appreciate the excellent technical assistance
provided by M. Buford (University of Montana),
H. Ringham and M. Fang (Indiana University),
and N. Corson (University of Rochester). We also
thank S. Nadadur, Program Director at the National
Institute of Environmental Health Sciences (NIEHS),
Division of Extramural Research and Training, for
initiating and directing these consortium efforts, and
T. Schug (NIEHS) for administrative organization
and planning of consortium conferences.
This work was supported by the American
Recovery and Reinvestment Act [ARRA, grants RC2
ES018742 (A.H.), RC2 ES018810 (F.W.), RC2
ES018786 (G.O.), RC2 ES018772 (J.C.B.), RC2
ES018766 (A.N.), RC2 ES018812 (C.V.), RC2
ES018741 (A.E.), and RC2 ES018782 (E.D.C.)].
Support was also provided by the Centers of
Biomedical Research Excellence [COBRE, grant P20
RR017670 (AH)].
The authors declare they have no actual or potential
competing financial interests.
Received 24 January 2013; accepted 1 April 2013.

683

Xia et al.

inflammasome assay on the basis of evidence
that a number of particles such as crystalline
silica, asbestos, uric acid crystals, and cholesterol
crystals activate the NLRP3 inflammasome,
causing the release of interleukin (IL)-1β and
IL-18 that have been linked to lung pathology
(Cassel et al. 2008; Dostert et al. 2008; Franchi
et al. 2009; Tschopp and Schroder 2010). For
example, one of the CPP laboratories recently
showed that TiO2-NBs stimulate the NLRP3
inflammasome in primary murine macrophages
(Hamilton et al. 2009). Here we describe the
outcomes of the consortium’s in vitro studies,
and Bonner et al. (2013) describe the in vivo
studies conducted in rodents using the same
well-characterized ENMs.
In the present study, the CPPs identified
and minimized critical aspects of current ENM
testing protocols that will potentially decrease
the variability in reported outcomes from the
various laboratories engaged in the field. In
addition, the results of this study provide new
information on the relative in vitro bioactivity of a large group of diverse ENMs that can
be used to inform future strategies for in vitro
testing and for predicting in vivo outcomes.

Materials and Methods
ENMs and reagents. The CPPs obtained
ZnO from Meliorum Technologies Inc.
(Rochester, NY). TiO 2-P25 (81% anatase
and 19% rutile) was purchased from Evonik
(Parsippany, NJ); TiO2-A was provided by
P. Biswas (Washington University, St. Louis,
MO); and the CPPs prepared the TiO2-NBs
as previously described (Hamilton et al.
2009). The CPPs obtained the O-MWCNT
stock in powder form from Cheap Tubes Inc.
(Brattleboro, VT); obtained the P-MWCNT
by treating O-MWCNT with dilute acids,
chelating agents, and mild conditions to minimize oxidized or damaged tubes; and created
F-MWCNT through further acid treatment
of P-MWCNT, which introduced carboxyl
groups on 5.27% of the carbon backbone (on
a per weight basis) (Chen and Mitra 2008;
Wang et al. 2011).
The CPPs purchased low-endotoxin
bovine serum albumin (BSA) from Gemini
Bio-Products (West Sacramento, CA);
dipalmitoylphosphatidylcholine, phorbol
12-myristate, 13-acetate (PMA), and lipopolysaccharide (LPS from Escherichia coli
0127:B8) from Sigma-Aldrich (St. Louis,
MO); and 1,25-dihydroxy-vitamin D3 from
EMD Millipore (Billerica, MA). The CPPs
purchased the cytotoxicity assays CellTiter
96 (MTS assay) and CytoTox 96 [LDH (lactate dehydrogenase) assay] from Promega
(Madison, WI).
Preparation of ENMs in cell culture
media. The CPPs prepared ENM stock solutions (5 mg/mL) from dry powder using
endotoxin-free sterile water and then prepared
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all ENM suspensions in cell culture media
using the stock solutions as needed. Briefly,
the CPPs vortexed and then sonicated
ENM stock solutions (with the exception
of TiO2-NB, which was stirred to prevent
mechanical shear) using a water bath sonicator
or cup horn sonicator (depending on laboratory availability) immediately before diluting
the solutions into complete cell culture media.
Cell culture and co-incubation with EMN.
The CPPs grew all cells at 37°C in a 5% CO2
atmosphere. RLE-6TN cells, a rat alveolar
type II epithelial cell line, from American
Type Culture Collection (ATCC; Manassas,
VA) were cultured in Ham’s F12 medium
(ATCC) supplemented with l-glutamine,
bovine pituitary extract (BPE), insulin, insulin
growth factor (IGF)-1, transferrin, and epithelial growth factor (EGF), supplemented with
10% fetal bovine serum (FBS). THP-1 cells,
a human acute monocytic leukemia cell line
(ATCC) were cultured in HEPES-buffered
RPMI 1640 supplemented with l-glutamine (Mediatech, Corning, NY), 0.05 mM
b-mercaptoe thanol, and 10% FBS (PAA
Laboratories, Dartmouth, MA). BEAS-2B
cells (ATCC) were cultured in bronchial epithelial growth medium (BEGM) obtained
from Lonza Inc. (Walkersville, MD) supplemented with BPE, insulin, hydrocortisone,
human EGF, epinephrine, triiodothyronine,
transferrin, gentamicin/amphotericin-B, and
retinoic acid. For the THP-1 differentiation
performed in the first series of experiments
(phase I), the CPPs pretreated cells with
1.62 µM (1 µg/mL) PMA for 18 hr. However,
the CPPs identified excessive cell clumping
and cell death during the phase I studies.
Therefore, the CPPs alternatively pretreated
THP-1 cells with vitamin D3 at 150 nM
overnight and then 5 nM PMA in order to
obtain the differentiated macrophage-like cells
used during the second series of experiments
(phase II). For the IL-1β release, co-culturing
THP-1 cells with 10 ng/mL LPS was necessary to initiate transcription of pro-IL-1β. The
CPPs initiated aggressive phagocytic activity
by adding PMA just before particle exposure.
Before ENM exposure, the CPPs cultured aliquots of 1.5 × 104 cells (for THP-1
cells, 105 cells were seeded into each well of
a 96-well plate) in 0.2 mL of the cell culture
media in 96-well plates (Costar, Corning, NY)
at 37°C for 24 hr. The CPPs freshly prepared
all of the ENM suspensions at final concentrations of 10, 25, 50, and 100 µg/mL in the
cell culture media. After exposure of the cells
to the ENMs for 24 hr at 37°C, the CPPs
collected supernatants to measure LDH and
IL-1β production then used the remaining
cells to test cellular viability by MTS assay.
Physicochemical characterization of
ENMs. The CPPs identified the primary
particle size and morphology of the ENMs
volume

by using a transmission electron microscope
(TEM; model 100CX) and a scanning electron microscope (SEM; model JSM-7600F)
(both from JEOL Ltd., Tokyo, Japan). In
addition, the CPPs characterized the particle
hydrodynamic size in H2O and cell culture
media using dynamic light scattering (DLS)
(Ji et al. 2010). The CPPs characterized particle crystallinity and structure using X-ray
diffraction measurements and measured
particle surface area by Brunauer–Emmett–
Teller (BET) surface area analysis. The CPPs
performed zeta-potential measurements of
the ENM suspensions using a ZetaSizer
Nano-ZS instrument (Malvern Instruments,
Worcestershire WR, UK). Finally, the CPPs
determined the elemental composition of the
particles as well as ZnO dissolution rate using
inductively coupled plasma mass spectrometry (ICP-MS) (model SCIEX Elan DRCII;
PerkinElmer, Norwalk, CT).
Endotoxin analysis of ENMs. CPPs measured the endotoxin content of ENM stock
suspensions, as well as dispersions in PBS and
tissue culture media, using the colorimetric
Limulus amebocyte lysate assay (Lonza Inc.).
The LPS content of all ENM suspensions
was < 0.3 EU/mL.
Determination of cell viability. The CPPs
determined cellular viability using MTS
(CellTiter 96) and LDH (CytoTox 96; both
from Promega) according to the manufacturer’s protocols. To avoid the interference
created by ENMs while measuring formazan
absorbance at 490 nm, the CPPs introduced
a centrifugation (2000 × g for 10 min) procedure in phase II experiments to collect particles
in the wells after incubation with the MTS
reagents. CPPs then followed this centrifugation step with a brief mixing and transfer of the
supernatant to a new 96-well plate before measuring the formazan absorbance at 490 nm.
The CPPs eliminated interference of any residual LDH in FBS by heat-inactivation (70°C
water bath for 5 min).
ELISA for IL-1β quantification. The CPPs
determined IL-1β production in the THP-1
culture supernatant using a human IL-1β
ELISA kit (R&D Systems Human IL-1β
DuoSet™; R&D Systems, Minneapolis, MN)
following the manufacturer’s instructions.
Statistical analysis. The CPPs used the twoway analysis of variance followed by Tukey or
Bonferroni correction for multiple comparisons of means for statistical analysis of responses
across ENMs and cell lines. In order to define
interlaboratory comparisons across two harmonization rounds, the CPPs conducted a
meta-analysis of LDH, MTS, and IL-1β assays
across eight different laboratories for three
cell lines (BEAS-2B, RLE-6TN, and THP-1)
exposed to several ENMs (TiO2-P25, TiO2-A,
TiO2-NBs, ZnO, O-MWCNT, P-MWCNT,
and F-MWCNT). The CPPs combined
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information within assays and cell lines using
a robust two-stage hierarchical model of toxicity. For all quantities of interest, the CPPs
obtained Monte Carlo inference by implementing a custom Gibbs sampler in the R computing environment (R Foundation for Statistical
Computing, Vienna, Austria). To normalize
data, the CPPs subtracted background negative
control values (MTS, LDH, and IL-1β) and
provided adjustments for positive control values
in the case of LDH assays. Details about the
statistical model used for analysis are provided
in Supplemental Material, p. 8 (http://dx.doi.
org/10.1289/ehp.1306561).
TiO2 -P25

Results
Physicochemical characterization of consortium ENMs. The consortium selected
two types of nanomaterials for the studies
in order to evaluate a sufficient number of
material types: a) metal oxides (TiO2-P25,
TiO2-A, TiO2-NBs, and ZnO), and b) three
multiwall carbon nanotubes (O-MWCNT,
P-MWCNT, and F-MWCNT). A key element of this study was that all of the investigators used the same sets of ENMs, which
had been extensively characterized a priori.
Representative SEM images show the morphology of the different ENMs: TiO2-P25,

TiO2 -NB

TiO2-A, and ZnO were spherical; TiO2-NBs
were straight, long fibers; O-MWCNT,
P-MWCNT, and F-MWCNT were long fibers
(Figure 1). The CPPs additionally characterized
the ENMs to determine size, surface area, crystal structure, and purity (Tables 1 and 2). To
determine the hydrodynamic size and charge
of these materials, the CPPs used both water
and cell culture media, respectively [in water,
Tables 1 and 2; for in media, see Supplemental
Material, Tables S1 and S2 (http://dx.doi.
org/10.1289/ehp.1306561)]. Functionalization
of MWCNT increased the negative surface
charge in water, as expected. It should be noted

TiO2 -A

O-MWCNT

ZnO

P-MWCNT

F-MWCNT

Figure 1. SEM images of ENMs: (A) TiO2-P25, (B) TiO2-NB, (C) TiO2-A, (D) ZnO, (E) O-MWCNT, (F) P-MWCNT, and (G) F-MWCNT.
Table 1. Physicochemical characterization of TiO2 and ZnO ENMs.
Quality
Size (nm)
Size in H2O (intensity-based) (nm ± SD)
Phase and structure
Shape/morphology
Surface area (m2/g)
Zeta potential in H2O at pH 6.0 (mV ± SD)
Elemental analysis (weight percent)

Technique
TEM
DLS
XRD
TEM
BET
Zetasizer
ICP-MS

TiO2-P25
~ 24
209 ± 8 (PdI 0.065)
81% anatase and 19% rutile
Spheroid
53
–34.4 ± 1.6
98.6

TiO2-A
~ 28
292 ± 70
100% anatase
Spherical
173
–30.7 ± 0.8
NA

TiO2-NBs
L:7000; W:200; T:10
2,897 ± 117
100% anatase
Belt
18
–30.3 ± 2.8
NA

ZnO
~ 20
215 ± 15 (PdI 0.033)
100% zincite
Spheroid
26
–28.2 ± 0.5
99.3

Abbreviations: L, length; NA, not available; PdI, polydispersity index; T, thickness; W, width; XRD, X-ray defraction.

Table 2. Physicochemical characterization of MWCNTs.
Quality
Size (nm)
Size in H2O (intensity-based) (nm ± SD)
Shape/morphology
Surface area (m2/g)
Zeta potential in H2O at pH 6.0 (mV ± SD)
Elemental analysis (weight percent)

Technique
TEM
DLS
TEM
BET
Zetasizer
ICP-MS

O-MWCNT
D: 20–30; L: 5,000–10,000
324 ± 33
Nanotube
180
–12.1 ± 0.3
4.5% Ni, 0.8% Fe

P-MWCNT
D: 20–30; L: 5,000–10,000
858 ± 58
Nanotube
513
–11.8 ± 1.1
1.8% Ni, 0.1% Fe

F-MWCNT
D: 20–30; L: 5,000–10,000
234 ± 24
Nanotube
26
–48.4 ± 1.7
0.2% S

Abbreviations: D, diameter; Fe, iron; L, length; Ni, nickel, S, sulfur.
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to a fresh plate to conduct the absorbance readings (Figure 2B, right). Figure 2C shows the
phase II results of MTS assay in RLE-6TN
cells using the updated protocols, and the
results demonstrated high consistency with low
variability among different laboratories.
Figure 2D,E shows the combined data
for the MTS assays using THP-1 cells. When
comparing the ENMs within each group, the
CPPs determined that ZnO was the most
toxic followed by TiO 2-NB. None of the
other ENMs caused any significant toxicity
as detected by the MTS assay. The combined
MTS data for the BEAS-2B and RLE-6TN
cells from all laboratories also showed clear
toxicity trends for ZnO [see Supplemental
Material, Figures S2A,C and S3A,C (http://
dx.doi.org/10.1289/ehp.1306561)].
Figure 2F compares reproducibility of
MTS assays between phases I and II. Stratifying
by ENM and cell line, the CPPs found that
both error in mean and measurement error
were either reduced or left unchanged when
comparing phase I with phase II data. Overall,
estimations show a 30% (95% CI: 5, 51%)
reduction in the error in mean between phase I
and phase II, with significant improvement in
reproducibility among laboratories. In addition, a 40% (95% CI: 13, 60%) reduction in
measurement error occurred between phase I
and phase II, showing substantially improved
within-laboratory repeatability.

laboratories were able to report full results. For
instance, some optical density readings were
> 2.0, and some laboratories had 100% cell
lysis values lower than the particle-exposed
values. These data were not usable and were not
included in the final results. The CPPs carried
out phase I studies with previously established
protocols used in the respective laboratories
of the consortium members. In contrast, the
CPPs conducted phase II studies using proto
cols developed after identifying and solving
technical problems in phase I. The CPPs
selected MTS and LDH assays because they
are the most commonly used single end point
cell viability assays for nanotoxicity studies in
the literature (Smith et al. 2011; Wang et al.
2010; Xia et al. 2008a). The relative simplicity
of the assay procedures allowed the studies to be
conducted concurrently.
MTS assays. The CPPs discovered substantial variations among the replicates within
individual laboratories in the phase I MTS
assays using BEAS-2B and RLE-6TN cells.
Figure 2A shows the low consistency for ZnO
MTS data using RLE-6TN cells in phase I
experiments. The CPPs determined that
ENMs interfered directly with the optical density readings (Figure 2B, left). Therefore, the
CPPs eliminated the optical interference by
adding a centrifugation procedure to isolate
the suspended ENM at the bottom of the cell
culture dish, then transferring the supernatants

Absorbance at 490 nm

that hydrodynamic diameters for nonspherical
particles such as nanotubes and nanowires are
defined as the equivalent spherical diameters
(i.e., the diameter of a sphere with the same
translational diffusion coefficient) and cannot
be simply related to the exact particle sizes.
Therefore, the hydrodynamic diameters measured here for TiO2-NBs and MWCNTs only
represent their “relative” sizes. DLS measurements provide a good indication of the dispersion state of high-aspect-ratio ENMs such as
MWCNTs (Wang et al. 2010) and cerium
oxide (CeO2) nanorods and nanowires (Ji
et al. 2012). For MWCNTs, the CPPs performed additional experiments using BEGM
medium (for BEAS-2B cells), showing that the
combination of BSA and 1,2-dipalmitoyl-snglycero-3 phosphocholine (DPPC) provided
optimal suspension stability (see Supplemental
Material, Figure S1A). In addition, because
ZnO has been shown to dissolve in aqueous
solutions, the CPPs determined the dissolution
rate of ZnO in water and BEGM and DMEM
media. At 24 hr, the percentage of dissolution
was 12%, 32%, and 35%, respectively (see
Supplemental Material, Figure S1B). Detailed
protocols and extra supplementary raw data
are available online [Center for Environmental
Health Sciences (CEHS) 2012].
Cytotoxicity of ENMs. In vitro studies
with ENMs involved eight laboratories and
included two phases. In some cases not all eight

0.4
0.3
0.2
0.1

Phase I

Phase II

0

Phase I

Phase II

Concentration (µg/mL)

Figure 2. Phase I/II comparisons for RLE-6TN and THP-1 cells using MTS assay data. (A) Percent viable RLE-6TN cells relative to no-particle control for each
individual laboratory in phase I. (B) The ENM distorted OD readings in the MTS assay: with the ENM in the culture well (left); with the media supernatant removed
and replaced in wells without particle interference (right); OD, optical density. (C) Percent viable RLE-6TN cells relative to no-particle control for each individual
laboratory in phase II. (D,E) Percent viable cells relative to no-particle control for THP-1 phase I conditions (D) and for THP-1 phase II conditions (E). (F) Changes
in error of the mean (left) and measure in error (right) from phase I to phase II trials for MTS assay data. Data are expressed as mean ± SE.
*p < 0.05 compared with other particles at the same concentration and/or the “no-particle” control.
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(40% decrease). Overall, assessments of the
improvement in assay performance showed
a 13% (95% CI: –0.12, 42%) improvement in reproducibility and 21% (95% CI:
–0.09, 53%) improvement in repeatability.
Inflammatory potential of ENMs. The
above studies demonstrated that only ZnO (all
models tested) and TiO2-NB (THP-1 only)
caused in vitro cytotoxicity. Because cyto
toxicity does not necessarily translate mecha
nistically to in vivo pathology, the consortium
studies included measurement of NLRP3
inflammasome generated IL-1β from THP-1
cells. The results of the phase I experiments
measuring IL-1β production using THP-1
cells demonstrated that only two laboratories
showed a significant increase from TiO2-NB
treatment (Figure 4A). The CPPs determined
that the interlaboratory inconsistency in the
phase I experimental results was possibly
due to cell clumping and excessive cell death
when using PMA alone for differentiation
(Figure 4B, left). In order to improve data
consistency, the CPPs modified the macrophage differentiation method by using vitamin D3 followed by a lower concentration of
PMA (Figure 4B, right). Figure 4C shows that
after using the improved protocols in phase II
studies, all laboratories reported significant
increases in IL-1β production in THP-1 cells
in response to TiO2-NB.
Figure 4D,E shows the combined data
from the phase I and phase II studies, respectively. The large error bars in phase I were
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due to the sizeable between-laboratory variation shown in Figure 4A. Consequently,
only TiO2-NB caused a nonsignificant dosedependent IL-1β release. In contrast, in
phase II the combined data demonstrated
that TiO 2-NB caused a significant IL-1β
release from THP-1 cells and MWCNTs
also increased IL-1β release, although the
results did not achieve significance when all
laboratories were averaged. The between-
laboratory variance and the large effect of the
TiO2-NBs negated any significance of the
MWCNT IL-1β dose-dependent increases
shown in Figure 4E. However, consideration
of the individual laboratory data showed a
significant dose-dependent increase for the
O-MWCNT in all but two laboratories [see
Supplemental Material, Figure S4 (http://
dx.doi.org/10.1289/ehp.1306561)]. In
every case, ranking the bioactivity of the
MWCNTs resulted in the following order:
O-MWCNT > P-MWCNT > F-MWCNT.
The probability of this rank order occurring in every laboratory by chance was
p < 0.001. In contrast ZnO, which was the
most cytotoxic of the ENMs, did not cause
any apparent IL-1β release regardless of dose
(Figure 4E).
Figure 4F shows the results comparing reproducibility of IL-1β assays between
phases I and II. Stratifying by ENM, comparisons of phase I and phase II data show
a reduction in both error in mean and measurement error. Combination of all ENMs

SD

LDH assays. Similar to the MTS assays,
the LDH assay results in response to ZnO
treatment of RLE-6TN cells improved in
the second phase of testing. Three laboratories showed high baseline levels in LDH in
phase I as compared with other laboratories
and did not have the same dose–response patterns exhibited by the majority of the laboratories (Figure 3A). In contrast, the procedural
improvements in phase II show a much better
agreement between laboratories (Figure 3B).
The combined data for the LDH assays
using THP-1 cells showed the same patterns
of toxicity compared with the MTS assays
(Figure 3C,D). The only two ENMs that
achieved significant toxicity using the LDH
assay were TiO2-NB and ZnO. Detailed summary LDH data for BEAS-2B and RLE-6TN
cells can be found in Supplemental Material,
Figures S2B,D and S3B,D (http://dx.doi.
org/10.1289/ehp.1306561).
Figure 3E reports the results comparing
the reproducibility of LDH assays between
phases I and II. Stratifying by ENM and cell
line, the CPPs found that both error in mean
and measurement error were either reduced
or left unchanged when comparing phase II
with phase I data. Only one ENM by cell line
combination (ZnO–RLE-6TN) exhibited
decreased reproducibility on average, but the
difference in errors was not statistically significant. Comparatively, for the same particle by
cell line combination, estimations of measurement error showed a substantial reduction
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Phase I
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Figure 3. Phase I/II comparisons for RLE-6TN and THP-1 cells using LDH assay data. (A,B) Percent LDH release in RLE-6TN cells relative to total cell lysis (100%
cell death) for each individual laboratory in phase I (A) and in phase II (B). (C,D) Percent LDH release relative to total lysis for THP-1 phase I conditions (C) and
for THP-1 phase II conditions (D). (E) Changes in error of the mean (left) and measure in error (right) from phase I to phase II trials for LDH assay data. Data are
expressed as mean ± SE.
*p < 0.05 compared with other particles at the same concentration and/or the “no-particle” control.

Environmental Health Perspectives •

volume

121 | number 6 | June 2013

687

Xia et al.

and cell lines showed an estimated 74%
(95% CI: 41, 95%) reduction in the error in
mean and significant improvement in reproducibility among laboratories. Furthermore,
within-laboratory repeatability improved substantially with an 83% (95% CI: 63, 99%)
reduction in measurement error.

Discussion
The NIEHS consortium conducted this study
in an effort to identify and minimize sources
of variability among laboratories performing in vitro testing of ENMs. Eight laboratories participated in all or part of two rounds
(phase I and phase II) of in vitro tests using
cell lines and ENM types that were collectively selected by consortium members. After
identification of several technical problems
in phase I, the CPPs significantly improved
the interlaboratory variability in phase II.
Furthermore, conclusions on the relative
potency of the different ENMs for both toxicity and bioactivity will contribute to the
information necessary to help predict relative risk for the ENMs. In addition, results
showed the MTS assay to be comparable in
data quality and predictive value when compared with the LDH assay for toxicity testing.
A significant finding of this study was that
the development of harmonized in vitro assay
protocols made it possible to achieve reproducible results among different laboratories.
This study was among the first attempts of
large scale round-robin tests of ENMs at the

For example, through close communication,
the CPPs determined that ENMs interfere
with optical density readings—creating artifacts and erroneous high MTS values (Kroll
et al. 2012). The phase I MTS assay protocol, as based on the Promega manufacturer’s
instructions, did not take into consideration
potential absorbance anomalies created by the
ENMs. As a result, although the combined
phase I MTS assays showed clear toxicity profiles of TiO2-P25, TiO2-A, TiO2-NB, and
ZnO in RLE-6TN and BEAS-2B cells [see
Supplemental Material, Figures S2 and S3
(http://dx.doi.org/10.1289/ehp.1306561)],
a large variation existed among the laboratories, as shown in Figure 2A. The CPPs determined this anomaly to be due to the presence
of residual ENM following treatment of the
cells, as demonstrated in Figure 2B. Therefore,
the phase II protocol introduced a simple centrifugation step and media removal after MTS
reagent incubation, thus allowing the absorbance to be read using supernatant containing
ENM-free MTS solution. This additional step
eliminated the ENM interference with the
assay and significantly improved the intra- and
interlaboratory consistency.
The CPPs determined ENM interference
to be only one potential source of variability
for in vitro assays. Phase I results of the LDH
and IL-1β assays clearly demonstrated that
cell culture conditions also contributed to
the observed variability. Stimulated release
of IL-1β from THP-1 cells relied in part on
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national and international level. There have
been reports of a successful effort to perform
interlaboratory comparisons to characterize
ENMs by establishing detailed shipping, measurement, and reporting protocols (Lamberty
et al. 2011; Roebben et al. 2011). Specifically,
researchers demonstrated a reduction in interlaboratory variations, especially for dynamic
scattering measurements (Roebben et al.
2011). In comparison, the present study outlined a novel method of in vitro testing using
multiple cell types, ENMs, and assays.
The planning of these in vitro tests
included steps to control for many factors. For
example, protocol development included consideration of varying cell culture conditions,
cell type, cell number, and cell viability, assay
protocols, and most important, experience
of the scientist that actually performed the
experiments. To this end, the CPPs obtained
cells and reagents from the same batch or
lot number and followed a detailed cell culture and assay protocol for each experiment.
Investigators and laboratory personnel established a mechanism to communicate with others and to share their experience in performing
specific assays. The frequent communication
was very helpful for achieving reproducible
results within and among the laboratories.
The strategies established for inter
laboratory communication provided a foundation for developing more effective protocols
during phase II studies to account for the
inherent difficulties in evaluating ENMs.

0
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Phase I

Phase II

Concentration (µg/mL)

Figure 4. Phase I/II comparisons for THP-1 cells using IL-1β assay data. (A) Percent IL-1β release from THP-1 cells for each individual laboratory in phase I.
(B) THP-1 cell differentiation technique altered cell morphology: THP-1 cells pretreated with 1.62 µM PMA for 24 hr formed clumps (left), whereas cells pretreated
with vitamin D3 overnight and then treated with 5 nM PMA were evenly dispersed (right). (C) IL-1β release from THP-1 cells for each individual laboratory in
phase II. (D,E) Summary IL-1β release for phase I conditions (D) and for phase II conditions (E). (F) Changes in error of the mean (left) and measure in error (right)
from phase I to phase II trials for IL-1β assay data. Data are expressed as mean ± SE.
*p < 0.05 compared with other particles at the same concentration and/or the “no-particle” control. #p < 0.001 for dose response (each laboratory’s data analyzed independently).
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the activation and differentiation of THP-1
cells by high levels of PMA in the phase I
protocol. PMA induced strong responses
in THP-1 cells, resulting in severe clumping of the THP-1 cells during the activation
process, in addition to excessive cell death
occurring upon scraping the cells. Using this
protocol, only two laboratories demonstrated
toxicity of TiO2-NBs in the MTS and LDH
assays or inflammasome activation in the
IL-1β assay in the phase I tests. However, by
replacing some of the PMA with vitamin D3,
a milder signal for THP-1 activation, the
cells remained well dispersed. Consequently,
phase II results demonstrated similar results
for IL-1β production by THP-1 cells stimulated with TiO2-NBs between laboratories.
Consortium efforts found that the MTS
assay was at least equal in reliability to assess
ENM toxicity as the LDH assay. Both toxicity assays tracked each other very well for
the different ENMs and cell types. Although
this finding needs further validation, it suggests that the easy-to-conduct MTS assay could
serve as a highly reliable testing method for
in vitro studies of ENM-induced cytotoxicity
when conducted as described in the phase II
protocol. Supplemental information is available online (CEHS 2012). The observation of
a difference in the relative potency between
TiO2-NB and ZnO between the two assays
is likely not as important as the observation
that both were significantly cytotoxic in vitro,
suggesting that both ENMs should be tested
in vivo.
The consortium studies also provided
reproducible findings of relative toxicity and
bioactivity of the various ENMs across the
different cell lines. For example, ZnO was
highly toxic to all three cell types examined
in this study, yet it did not stimulate inflammasome activity in THP-1 cells (Figure 4),
suggesting that cytotoxicity and bioactivity
(e.g., stimulation of inflammasome-mediated
IL-1β release) do not necessarily correlate.
Studies on inflammation and lung pathology
implicate the importance of inflammasomegenerated IL-1β production (Cassel et al.
2008; Dostert et al. 2008; Franchi et al. 2009;
Tschopp and Schroder 2010). In addition, a
consortium laboratory recently demonstrated
the importance of IL-1β release in generating an inflammatory response to MWCNTs
in vivo (Girtsman et al. 2012). Therefore,
the consortium recommends the inclusion
of mechanism-linked bioactivity assays along
with traditional cytotoxicity assays for in vitro
ENM screening.
The two forms of TiO2 nanospheres (P25
and A) were not significantly cytotoxic or
bioactive, yet TiO2-NBs were highly cytotoxic and selectively induced inflammasome
activity toward THP-1 cells, consistent with
previous studies (Hamilton et al. 2009). The
Environmental Health Perspectives •

volume

lack of toxicity of the TiO2-NBs toward epithelial cells can probably be explained by their
poor internalization of the material, and suggests that if in vitro studies were conducted
solely with epithelial cell lines such as those
used in this study, the high toxicity of this
material would not have been identified.
Consequently, an important recommendation
is to conduct studies with multiple relevant
cell types to avoid false-negative outcomes.
In parallel with the in vitro studies, another
consortium effort among seven different laboratories conducted in vivo studies using rats,
mice, and most of the ENMs described in the
present study. These researchers performed
similar efforts to address technical issues and
methods to reduce variability (Bonner et al.
2013). The CPPs in vitro TiO2 studies predicted the in vivo outcomes with more laboratories observing significant lung inflammation
with the TiO2-NBs compared with the two
nanosphere forms. The results presented in
this study are also consistent with a recent
report demonstrating that TiO2-NBs, but not
nanospheres, caused lung fibrosis (Porter et al.
2013). Furthermore, observations showed a
greater activity of O-MWCNT compared
with P-MWCNT or F-MWCNT. Therefore,
the in vitro studies had the potential to accurately predict the relative potency for the
TiO2 materials observed in vivo. In fact, the
IL-1β (proxy measure for NLRP3 inflammasome) result from this study would predict
that the TiO 2-NBs and the O-MWCNT
would be the two ENMs that would result
in the greatest inflammation, and that was
confirmed in the corresponding in vivo work
(Bonner et al. 2013).

Conclusions
These studies strove to improve concordance
of test results among laboratories while ensuring that the assays were predictive of in vivo
outcome. The CPPs achieved the goal of producing reliable and repeatable in vitro toxicity
testing for ENMs; however, improving the
predictability of the assays is still a work in
progress. Care needs to be taken to understand
the limitation of in vitro testing and not to
overinterpret in vitro studies without comprehensive companion in vivo studies. These
studies used well-characterized nanomaterials,
including a positive and negative control, in
addition to a well-established dispersion protocol ensuring stable suspensions in cell culture media. This consortium effort provided
a series of harmonized protocols and tested
models for the nanotoxicological field to use.
The results also demonstrated that toxicity and
inflammasome activity did not always track
each other and that different cell types yielded
different estimates of safety of different ENMs.
Consequently, future studies should utilize
multiple end points and multiple cell types to

121 | number 6 | June 2013

avoid false-negative results. Finally, this effort
serves as a good template for future endeavors in the field of nanotoxicology, providing
key elements necessary for collaborative efforts
between laboratories.
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